BIOS 29. Translating SynBio w/ Jim Collins - Professor @ MIT / Core Faculty @ Wyss Institute
Oct 28, 2021
Jim Collins, a pioneer in synthetic biology and Professor at MIT, discusses his journey from physics to groundbreaking innovations in healthcare. He highlights the transformative potential of AI and CRISPR technology in addressing global challenges like antibiotic resistance and rapid diagnostics, particularly during the COVID-19 pandemic. Collins shares insights on ethical leadership in biotech and the importance of empowering the next generation of innovators, emphasizing a future where synthetic biology revolutionizes sustainability and health.
AI Snips
Chapters
Transcript
Episode notes
SynBio's Impact on Healthcare
- Synthetic biology is maturing, impacting healthcare through mRNA vaccines and diagnostics.
- Its programmable nature allows organisms to sense, decide, and act, transforming healthcare.
Problem Selection
- Focus on exciting, low-risk, high-gain projects.
- Avoid low-gain projects and excessive focus on high-risk ones in academia.
Sherlock Biosciences and Diagnostics
- Collins's lab developed paper-based diagnostics using freeze-dried cell-free synthetic biology.
- This led to Sherlock Biosciences, which created the first FDA-approved CRISPR-based diagnostic.